Using AI to De-Risk Rare Disease Drug Development

RARECast - A podcast by RARECast - Thursdays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Categories:

Tim Guilliams, co-founder and CEO of Healx, discusses the origin of the company, its lead asset in development for neurofibromatosis type 1, and how he views the company’s progress to date.

Visit the podcast's native language site